DNAnexus, Inc., a leader in precision health data platforms, and Panomics, Inc., specializing in AI-powered omics data management and discovery for biopharma, have announced a strategic collaboration. This partnership will deliver biopharma organizations a comprehensive solution for multi-omics data management and analysis, enhancing transcriptomics and proteomics workflows for biomarker discovery and drug repurposing.
DNAnexus, a leader in precision health data platforms, and Panomics, a provider of AI-powered omics data management for biopharma, have announced a strategic collaboration to offer biopharma organizations a comprehensive multi-omics data management and analysis solution. As part of this collaboration, Panomics’ suite of interactive data analysis tools and advanced analytics capabilities will be integrated into DNAnexus’ Cohort Browser. This will enable biopharma researchers to conduct large-scale, interactive analyses of complex, multimodal datasets within a secure, cloud-based environment. Researchers will be able to dynamically filter, visualize, and query data, uncovering valuable insights and identifying key patterns.
Radu Andrei Tanasa, founder and CEO of Panomics, stated, “DNAnexus has built the world’s most secure precision health data platform for biopharma enterprises. The combination of our technologies will empower researchers to perform real-time analyses that accelerate drug discovery timelines and facilitate the identification of potential drug repurposing candidates by searching for similar biological signatures.”
DNAnexus currently supports over 45,000 registered users across 48 countries and manages more than 105 petabytes of complex clinical, genomic, proteomic, and other multi-omic data. Its platform adheres to the highest standards for data quality, security, privacy, and regulatory compliance.
Thomas Laur, CEO of DNAnexus, commented, “Our collaboration with Panomics is a major step forward in providing biopharma researchers with an advanced, interactive platform for managing multi-omics data and advancing precision health. This partnership underscores our ongoing commitment to enhancing our platform and offering the most sophisticated tools to unlock insights from large-scale multi-omic datasets.”
About Panomics
Founded in 2022, Panomics is a biotechnology research company focused on integrating data from genomics, transcriptomics, proteomics, and metabolomics to better understand biological systems. Their innovative SaaS and PaaS platform is designed to revolutionize how biopharma companies manage, process, and extract insights from complex multi-omics samples, helping accelerate drug discovery and development.
About DNAnexus
DNAnexus is a leading enterprise platform for precision health data, dedicated to accelerating the development, approval, and delivery of personalized treatments. With over 15 years of bioinformatics and genomics expertise, DNAnexus powers a connected data ecosystem trusted by leaders in precision health. This flexible ecosystem makes omics and real-world data accessible, actionable, and secure, unlocking insights that improve patient outcomes.
